UT System Health Council
Home | About Us | Funded Proposals | Faculty Members
About Us
Funded Proposals
Faculty Members
Studies/Reports
Faculty Member

Susan P. Fisher-Hoch, Professor
The University of Texas Health Science Center - School of Public Health

Education

Royal College of Pathologists Membership 1982 Virology
University of London Degree (MD) 1981 Epidemiology
University of London, LSHTM Distinction Doctoral 1978 Medical Microbiology
University of London, Royal Free Hospital MB BS, First Class MSc 1975 Medicine

Positions and Employment

1975 - 1976 House Officer, Dr. Sheila Sherlock, Liver Unit, Royal Free Hospital, London, UK
1976 - 1979 Microbiologist, Public Health Laboratories, John Radcliffe Hospital, Oxford, UK
1979 - 1982 Senior Registrar, Department of Virology, St. George's Hospital Medical School, UK
1985 - 1986 Consultant Medical Microbiologist, Director, Special Pathogens Laboratory, Porton Down, UK
1986 - 1990 Deputy Branch Chief, Special Pathogens Branch, Division of Viral and Rickettsial Diseases, CDC. (April to October 1988, Acting Branch Chief, Special Pathogens Branch.)
1990 - 1993 Senior Medical Epidemiologist, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases
1993 - 1997 Research Professor, Department of Pathology, Aga Khan University Medical School, Pakistan
1997 - 2000 Directeur, Laboratoire, Jean Mérieux, BSL4, Fondation Marcel Mérieux, Lyon, France
2001 - present Professor, Epidemiology, UT School of Public Health, Brownsville Campus

Experience and Honors

1970 Elizabeth Garrett Anderson Scholarship, Royal Free Hospital School of Medicine
1970 - 1976 6 preclinical and clinical prizes. Royal Free School of Medicine
1986 - 1991 Sierra Leone Responsible for CDC Lassa Fever field froject
1986 - 1989 China Established Hantavirus studies
1987 - 1989 South Africa/Senegal Epidemic investigation of CCHF
1989 Nigeria Epidemic investigation of Lassa fever
1989 Amsterdam/Indonesia. Investigation of Ebola infection in non-human primates in transit
1990 Saudi Arabia: Investigation of outbreak of CCHF in Mecca and Jeddah
1992 Member panel of advisors for Review of Infectious Diseases Program for DOD
1995 Kenya and Tanzania Consultant to AKHS,K for blood banking and HIV screening procedures
1998 Gabon Review of Ebola program for CIRMF
1999 Liberia: Consultation for Merlin Refugee Agency, Lassa Fever
2003 Friends of Public Health Award, Texas Department of Health

Publications

  1. Fisher-Hoch SP, Bartlett, C.L.R., Tobin, J.O'H, et al, Investigation and control of an outbreak of Legionnaires' Disease in a District General Hospital. Lancet 1981;i:932-936.
  2. Fisher-Hoch SP, Platt GS, Neild GH, Southee T, Baskerville A, Raymond RT, Lloyd G, Simpson DIH. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis 1985;152-:887-94.
  3. Fisher-Hoch SP, Mitchell SW, Sasso DR, Lange JV, Ramsey R, McCormick JB. 1987 Physiological and immunological disturbances associated with shock in a primate model of Lassa fever. J.Infect.Dis;155:465-474.
  4. Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. 1988 Prospective study of maternal and fetal outcome in acute Lassa fever during pregnancy. Br Med J;297:584-588.
  5. Cummins D, Fisher-Hoch SP, Walshe K, Mackie IJH, Bennet D, Perez G, Farrar B, Machin SJ, McCormick JB. A plasma inhibitor of platelet aggregation in patients with Lassa fever. Br. J. Hematol. 1989;72:543-548.
  6. Fisher-Hoch SP, McCormick JB, Auperin D, Brown BG, Castor M, Perez G, Ruo S, Conaty A, Brammer L, Bauer S. 1989 Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. PNAS 85:317-321.
  7. Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, Hall PA, Brammer LS, Perez-Oronoz G, McDonnell MK, Paulissen JP, Schonoberger LB, Fisher-Hoch SP. Lassa fever in the United States: Investigation of a case and new guidelines for management. NEJM 1990;323:1120-1123.
  8. Fisher-Hoch SP, Brammer TL, Trappier SG, Hutwagner LC, Farrar BB, Ruo SL, Brown BG, Hermann LM, Perez-Oronoz GI, Goldsmith CS, Hanes MA, McCormick JB. Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J.Infect.Dis. 1992;166:753-763.
  9. Fisher-Hoch SP, Perez-Oronoz GI, Conaty AL, Jackson EL, Hermann LM, Brown BG. Filovirus clearance in non-human primates. Lancet. 1992;340:451-453.
  10. Ruo SL, Yong LL, Sheng T, MA QR, Liu ZL, Tang YW, De LY, Zhi YX, McCormick JB, Fisher-Hoch SP. Retrospective and prospective studies of hemorrhagic fever with renal syndrome in rural China. J Inf Dis 1994;170:527-534.
  11. Fisher-Hoch SP, Hutwagner L. Opportunistic Candidiasis: an epidemic of the 1980s. Clin. Infect. Dis. 1995;21(4):897-904.
  12. Fisher-Hoch SP, Tomori O, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 1995;311:857-859.
  13. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean-Congo hemorrhagic fever treated with oral ribavirin. Lancet 1995;346:472-475.
  14. Baize S, Leroy EM, Georges-Courbot M-C, Fisher-Hoch SP, Debré P, Capron M, Lansoud-Soukate J, Georges AJ. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola Virus-infected patients. Nature Medicine, 1999;5:423-426.
  15. Fisher-Hoch SP, Hutwagner, Brown B, and McCormick JB. (2000). Effective vaccine for Lassa fever. J. Virol. 74,6777-6783.
  16. Leroy Em, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansound-Soukate J, Capron M, Debré P, McCormick JB and Georges AJ. (2000). Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355, 2210-2215.
  17. Mirza S, Restrepo BI, McCormick JB, Fisher-Hoch SP. Diagnosis of tuberculosis lymphadenitis using a polymerase chain reaction on peripheral blood mononuclear cells. 2003, A.J.T.M.H. 69:461-5.
  18. Perez A, Anzaldua M, McCormick J, Fisher-Hoch SP. High frequency of chronic end-stage liver disease and hepatocellular carcinoma in a Hispanic population. J Gastroenterol Hepatol. 2004 Mar;19(3):289-295.
  19. Parent, d.C. I, Merchant AT, Fisher-Hoch SP, Luby SP, Plotkin SA, Moatter T, Agboatwalla M, and McCormick JB. (2003). Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules. Vaccine 21, 1710-1817.
  20. Fisher-Hoch SP, McCormick JB. Biocontainment in Developing Countries. 2004 Anthology of Biosafety VII:BSL3, Ed Jonathan Richmond. American Biological Safety Association, Mundelein, II:95-108.
  21. Haws AL, Woeber S, Gomez M, Garza N, Gomez Y, Rady P et al. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer. J Med Virol 2005 October;77(2):265-72.
  22. Fisher-Hoch SP, MJ. Biocontainment in Developing Countries. In: Jonathan Y R, editor. Anthology of Biosafety: VII: Biosafety Level 3. Mundelein, Illinois: American Biological Safety Association; 2004. p.95-108.
  23. Fisher-Hoch SP, McCormick JB. Lassa fever vaccine. Expert Rev Vaccines 2004 April;3(2):189-97.
  24. Fisher-Hoch SP. Lessons from nosocomial viral haemorrhagic fever outbreaks. British Medical Bulletin 2006. In press.

Research Support

ACTIVE

1R01DP000210-01 PI: McCormick 07/15/2005 - 03/14/2007 5%
CDC   $348,630.00  
Genetic, Behavioral and Lifestyle risk factors for complications of Type 2 Diabetes in a Mexican American
We propose to expand the existing funded and approved cohort study we have established among the Mexican-American population in the Lower Rio Grande Valley. Our strategy is therefore to exploit the interaction of genomics with behavioral, socioeconomic and lifestyle measures to provide the most robust measures of the components which predispose and lead to T2DM and its complications.
 
1R21AI064297-01A1 PI: Restrepo 06/15/2006 - 05/31/2008 2%
NIH   $150,000.00  
Rapid Characterization of Mycobacteria and Drug Resistance in Paucibacillary TB
Our School is located in South Texas, less than 1 mile from the Mexico border, in a region with one of the highest rates of drug resistance (DR) and multi drug-resistant (MDR) tuberculosis (TB) in the United States.

Our successful collaboration with tuberculosis health officials from both sides of the border provides us with easy access to patient information and specimens.
 
5P20MD000170-04 PI: McCormick 03/03/2003 - 2/29/2008 20%
NIH   $980,617.00  
EXPORT - Creation of a Hispanic Health Research Center in the Lower Rio Grande Valley (LRGV)
Develop research capacity in a nucleus of individuals in partner minority serving academic institutions in the LRGV; transfer of scientific technology and expertise to the LRGV; create capacity for collecting, managing, and disseminating information on Hispanic Health locally, regionally and eventually globally; develop community participatory research and intervention strategies specific for Hispanic (Mexican American) cultures; develop the HHRC into a collaborative center for Hispanic Health Research with other institutions.

Return to Top
 
Maintained by UTPA/Internet Services
Contact webmaster
UT System | UT System Leadership | State of Texas | Statewide Search | TRAIL | DMCA